Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomoda makes Maria Zannes CEO

This article was originally published in Clinica

Executive Summary

Maria Zannes has been appointed CEO of Biomoda, a company specialising in cancer diagnostics. Ms Zannes is also the firm’s chairman and has previously worked as a consultant for private clients in the medical, energy and environmental industries. She replaces John Cousins, who will remain Biomoda’s president and CFO. The Albuquerque, New Mexico-based company is currently seeking FDA approval for its CyPath diagnostic assay, which is designed to detect lung cancer at an early stage. Biomoda also has tests for cervical, breast, colorectal, bladder and oral cancers in the pipeline.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096394

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel